Form D · Biotechnology
Valfix Medical Inc.
Tel Aviv Yafo, L3 · CIK 0001789249
Offering snapshot reported Oct 10, 2019 · SEC filing
- Reported sold
- $1.13M Offering amount: $1.7M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Aug 22, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 10, 2019 | Initial | $1,125,000 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-350788
Source: Form D, filed Oct 10, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Eli Bar | Director, Executive |
| Gary Gershony | Director |
| Philip Lavin | Director |
| Elad Yaacoby | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
126 Yigal Alon Street
Tel Aviv Yafo, L3, 6744332
Tel Aviv Yafo, L3, 6744332